PH25512A - Piperazinecarboxylic acid, pharmaceutical compositions containing it - Google Patents

Piperazinecarboxylic acid, pharmaceutical compositions containing it

Info

Publication number: PH25512A
Authority: PH; Philippines
Prior art keywords: pharmaceutical compositions; compositions containing; piperazinecarboxylic acid; piperazinecarboxylic; acid
Prior art date: 1987-02-18

Application number

PH36514A

Other languages

English (en)

Inventor

Bernhard Aebischer

Original Assignee

Sandoz Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-18

Filing date

1988-02-16

Publication date

1991-07-24

1988-02-16 Application filed by Sandoz Ltd filed Critical Sandoz Ltd

1991-07-24 Publication of PH25512A publication Critical patent/PH25512A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PH36514A 1987-02-18 1988-02-16 Piperazinecarboxylic acid, pharmaceutical compositions containing it PH25512A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878703749A GB8703749D0 (en)	1987-02-18	1987-02-18	Piperazinecarboxylic acid

Publications (1)

Publication Number	Publication Date
PH25512A true PH25512A (en)	1991-07-24

Family

ID=10612501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH36514A PH25512A (en)	1987-02-18	1988-02-16	Piperazinecarboxylic acid, pharmaceutical compositions containing it

Country Status (28)

Country	Link
JP (1)	JPH0723387B2 (pt)
KR (1)	KR960015190B1 (pt)
AT (1)	AT391320B (pt)
AU (1)	AU613009B2 (pt)
BE (1)	BE1002427A3 (pt)
CA (1)	CA1327799C (pt)
CH (1)	CH675125A5 (pt)
CY (1)	CY1739A (pt)
DE (1)	DE3804936C2 (pt)
DK (1)	DK168441B1 (pt)
ES (2)	ES2011319A6 (pt)
FI (1)	FI86733C (pt)
FR (1)	FR2610932B1 (pt)
GB (2)	GB8703749D0 (pt)
GR (1)	GR1002471B (pt)
HK (1)	HK142093A (pt)
HU (2)	HU199858B (pt)
IE (1)	IE59098B1 (pt)
IL (1)	IL85436A0 (pt)
IT (1)	IT1219447B (pt)
LU (1)	LU87129A1 (pt)
MY (1)	MY103206A (pt)
NL (1)	NL8800412A (pt)
NZ (1)	NZ223529A (pt)
PH (1)	PH25512A (pt)
PT (1)	PT86776B (pt)
SE (1)	SE467256B (pt)
ZA (1)	ZA881146B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU202111B (en) *	1988-03-11	1991-02-28	Sandoz Ag	Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) *	1990-06-18	1992-02-04	The United States Of America As Represented By The Department Of Health And Human Services	Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) *	1990-11-28	1992-08-05	Sandoz Ltd.	New uses of competitive nmda receptor antagonists
US5260286A (en) *	1992-10-16	1993-11-09	Japan Tobacco, Inc.	2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
AU5693996A (en) *	1995-05-08	1996-11-29	Lonza A.G.	Biotechnical production process of piperazine r-alpha-carbox ylic acids and piperazine s-alpha-carboxylic acid amide
ES2206928T3 (es)	1997-05-12	2004-05-16	Ortho-Mcneil Pharmaceutical, Inc.	Piperacinas sustituidas con arilo utiles en el tratamiento de la hiperplasia benigna de prostata.
GB9821179D0 (en) *	1998-09-30	1998-11-25	Merck Sharp & Dohme	Therapeutic use
JP2008124531A (ja)	2006-11-08	2008-05-29	Nec Electronics Corp	半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en)	2017-07-13	2019-01-16	Paris Sciences et Lettres - Quartier Latin	Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1248531A (en) *	1984-04-17	1989-01-10	Jeffrey C. Watkins	4-substituted piperazine-2-carboxylic acids

1987
- 1987-02-18 GB GB878703749A patent/GB8703749D0/en active Pending
1988
- 1988-02-11 LU LU87129A patent/LU87129A1/fr unknown
- 1988-02-12 FR FR888801782A patent/FR2610932B1/fr not_active Expired - Lifetime
- 1988-02-12 BE BE8800177A patent/BE1002427A3/fr active
- 1988-02-12 IT IT47631/88A patent/IT1219447B/it active
- 1988-02-15 MY MYPI88000155A patent/MY103206A/en unknown
- 1988-02-15 GB GB8803438A patent/GB2201676B/en not_active Expired - Lifetime
- 1988-02-16 NZ NZ223529A patent/NZ223529A/xx unknown
- 1988-02-16 DK DK079688A patent/DK168441B1/da not_active IP Right Cessation
- 1988-02-16 HU HU88746A patent/HU199858B/hu not_active IP Right Cessation
- 1988-02-16 PH PH36514A patent/PH25512A/en unknown
- 1988-02-16 CH CH549/88A patent/CH675125A5/de not_active IP Right Cessation
- 1988-02-16 CA CA000559170A patent/CA1327799C/en not_active Expired - Fee Related
- 1988-02-16 IE IE41388A patent/IE59098B1/en not_active IP Right Cessation
- 1988-02-16 AU AU11758/88A patent/AU613009B2/en not_active Ceased
- 1988-02-16 GR GR880100084A patent/GR1002471B/el not_active IP Right Cessation
- 1988-02-16 IL IL85436A patent/IL85436A0/xx not_active IP Right Cessation
- 1988-02-17 JP JP63036458A patent/JPH0723387B2/ja not_active Expired - Lifetime
- 1988-02-17 FI FI880744A patent/FI86733C/fi not_active IP Right Cessation
- 1988-02-17 DE DE3804936A patent/DE3804936C2/de not_active Expired - Fee Related
- 1988-02-17 KR KR1019880001680A patent/KR960015190B1/ko not_active IP Right Cessation
- 1988-02-17 SE SE8800541A patent/SE467256B/sv not_active IP Right Cessation
- 1988-02-17 PT PT86776A patent/PT86776B/pt not_active IP Right Cessation
- 1988-02-17 AT AT0036788A patent/AT391320B/de not_active IP Right Cessation
- 1988-02-18 ZA ZA881146A patent/ZA881146B/xx unknown
- 1988-02-18 NL NL8800412A patent/NL8800412A/nl not_active Application Discontinuation
- 1988-02-18 ES ES888800466A patent/ES2011319A6/es not_active Expired - Lifetime
1989
- 1989-10-16 ES ES8903482A patent/ES2021904A6/es not_active Expired - Lifetime
1993
- 1993-12-30 HK HK1420/93A patent/HK142093A/xx not_active IP Right Cessation
1995
- 1995-06-09 HU HU95P/P00176P patent/HU211269A9/hu unknown
- 1995-10-20 CY CY173995A patent/CY1739A/xx unknown

Also Published As

Publication number	Publication date
ES2021904A6 (es)	1991-11-16
IE59098B1 (en)	1994-01-12
HK142093A (en)	1994-01-07
KR960015190B1 (ko)	1996-11-01
MY103206A (en)	1993-05-29
IT8847631A0 (it)	1988-02-12
AU613009B2 (en)	1991-07-25
FI880744A0 (fi)	1988-02-17
ATA36788A (de)	1990-03-15
CA1327799C (en)	1994-03-15
NZ223529A (en)	1991-02-26
ZA881146B (en)	1989-10-25
ES2011319A6 (es)	1990-01-01
FR2610932A1 (fr)	1988-08-19
DE3804936C2 (de)	1997-02-13
HUT49361A (en)	1989-09-28
GB8803438D0 (en)	1988-03-16
IL85436A0 (en)	1988-07-31
DK79688D0 (da)	1988-02-16
DE3804936A1 (de)	1988-09-01
HU199858B (en)	1990-03-28
CH675125A5 (pt)	1990-08-31
DK79688A (da)	1988-08-19
IE880413L (en)	1988-08-18
PT86776B (pt)	1992-05-29
JPH0723387B2 (ja)	1995-03-15
GR880100084A (el)	1988-12-16
FI86733B (fi)	1992-06-30
GB2201676B (en)	1991-01-02
GB8703749D0 (en)	1987-03-25
KR880009944A (ko)	1988-10-06
IL85436A (pt)	1992-12-01
IT1219447B (it)	1990-05-18
BE1002427A3 (fr)	1991-02-05
DK168441B1 (da)	1994-03-28
LU87129A1 (fr)	1988-09-20
FI880744A (fi)	1988-08-19
AT391320B (de)	1990-09-25
GB2201676A (en)	1988-09-07
SE8800541D0 (sv)	1988-02-17
CY1739A (en)	1995-10-20
NL8800412A (nl)	1988-09-16
FR2610932B1 (fr)	1990-11-16
PT86776A (pt)	1988-03-01
HU211269A9 (en)	1995-11-28
FI86733C (fi)	1992-10-12
GR1002471B (el)	1996-11-15
SE467256B (sv)	1992-06-22
AU1175888A (en)	1988-08-25
JPS63203691A (ja)	1988-08-23

Publication	Publication Date	Title
GB8810477D0 (en)	1988-06-08	Pharmaceutical compositions
ZA883212B (en)	1989-03-29	Pharmaceutical compositions
GB8826321D0 (en)	1988-12-14	Pharmaceutical compositions
EG18652A (en)	1993-10-30	Pharmaceutical compositions
PH25512A (en)	1991-07-24	Piperazinecarboxylic acid, pharmaceutical compositions containing it
GB8804697D0 (en)	1988-03-30	Pharmaceutical compositions
IL87130A0 (en)	1988-12-30	Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them
GB8810716D0 (en)	1988-06-08	Pharmaceutical compositions
EP0300036A4 (en)	1989-06-14	PHARMACEUTICAL COMPOSITIONS BASED ON VASOPRESSIN.
ZA888391B (en)	1989-08-30	Pharmaceutical compositions
GB8713091D0 (en)	1987-07-08	Pharmaceutical compositions
GB8814615D0 (en)	1988-07-27	8-acrylaminoergoline its preparation & pharmaceutical compositions containing it
ZA882861B (en)	1988-12-28	Pharmaceutical compositions
GB8827838D0 (en)	1988-12-29	Pharmaceutical compositions
GB8716380D0 (en)	1987-08-19	Pharmaceutical compositions
GB8716784D0 (en)	1987-08-19	Pharmaceutical compositions
GB8720003D0 (en)	1987-09-30	Pharmaceutical compositions
IE871141L (en)	1987-11-05	Pharmaceutical compositions
GB8723187D0 (en)	1987-11-04	Pharmaceutical compositions
GB8710967D0 (en)	1987-06-10	Pharmaceutical compositions
GB8716783D0 (en)	1987-08-19	Pharmaceutical compositions
GB8716434D0 (en)	1987-08-19	Pharmaceutical compositions
GB8700811D0 (en)	1987-02-18	Pharmaceutical compositions
GB8700812D0 (en)	1987-02-18	Pharmaceutical compositions
GB8706258D0 (en)	1987-04-23	Pharmaceutical compositions